Andrea Babelova

7PUBLICATIONS
11CO-AUTHORS
Molecular targetsBiologically active moleculesMolecular medicineNanotoxicology, health and safetyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 18, 2025
Cellular and molecular mechanisms of cancer drug resistance.

Miroslava Matuskova, Andrea Babelova

|Aug 08, 2025
Isosilybin B: a potential novel therapeutic agent with hepatoprotective, anticancer and antifibrotic properties.

Michal Selc, Kristina Jakic, Radka Macova

|Oct 24, 2024
Novel Strategies Enhancing Bioavailability and Therapeutical Potential of Silibinin for Treatment of Liver Disorders.

Michal Selc, Radka Macova, Andrea Babelova

|Jun 03, 2024
ASP210: a potent oligonucleotide-based inhibitor effective against TKI-resistant CML cells.

Veronika Nemethova, Petra Babiakova, Boglarka Teglasova

|May 13, 2024
Long-Term Accumulation, Biological Effects and Toxicity of BSA-Coated Gold Nanoparticles in the Mouse Liver, Spleen, and Kidneys.

Kristina Jakic, Michal Selc, Filip Razga

|May 06, 2022
Surface coating determines the inflammatory potential of magnetite nanoparticles in murine renal podocytes and mesangial cells.

Michal Selc, Filip Razga, Veronika Nemethova

Pageof 2

Frequent Collaborators

3 joint publications

Michal Selc

1 joint publications

Lubos Drgona

1 joint publications

Filip Razga

1 joint publications

Michal Sramek